ENA-001

DRUG2 trials

Sponsors

Enalare Therapeutics Inc.

Conditions

Respiratory Depression

Phase 1

ENA-001 for Opioid Induced Respiratory Depression

CompletedNCT06967259

Enalare Therapeutics Inc.Respiratory Depression

Start: 2025-05-14End: 2026-08-12Updated: 2026-09-16

Phase 2

ENA-001 for Post Operative Respiratory Depression (PORD)

Not yet recruitingNCT06137638

Enalare Therapeutics Inc.Respiratory Depression

Start: 2026-12-15End: 2027-07-15Target: 200Updated: 2026-02-27